Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00212264 · ClinicalTrials.gov registry record · NA

Conservative Treatment of Postprostatectomy Incontinence

A NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
NA
Development phase
208
Enrollment target

NCT00212264: Completed NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

NCT00212264 is a NA study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 208 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00212264, a NA study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
NA
Development phase
208 participants
Enrollment target

Study Summary

The primary purpose of this study is to test the effectiveness, impact on quality of life, and durability of non-surgical therapies for incontinence persisting at least one year after surgery. The study is a a prospective, controlled, randomized trial comparing an 8-week, multi-component behavioral training program (pelvic floor muscle exercises, self-monitoring with bladder diaries, regular office visits, bladder control techniques, and fluid management) to the same program with the addition of biofeedback and pelvic muscle electrical stimulation.

Primary Outcome

\[(Baseline incontinence episodes minus 2-month incontinence episodes)/baseline incontinence episodes\] x 100%

Interventions

  • BEHAVIORAL Biofeedback
  • OTHER No Treatment
  • BEHAVIORAL Behavioral Therapy
  • DEVICE Pelvic Floor Electrical Stimulation

Trial Details

FieldValue
Enrollment Target 208 participants
Start Date 2003-08
Est. Completion 2011-08
Phase NA

What the finished NCT00212264 record still lists

NCT00212264 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 4 interventions - of which Biofeedback is the first listed.

NCT00212264 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00212264 about?

NCT00212264 is a clinical study titled "Conservative Treatment of Postprostatectomy Incontinence". The primary purpose of this study is to test the effectiveness, impact on quality of life, and durability of non-surgical therapies for incontinence persisting at least one year after surgery. The study is a a prospective, controlled, randomized trial comparing an 8-week, multi-component behavioral ...

What is the current status of trial NCT00212264?

This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2003-08. Estimated completion is 2011-08.

What interventions are being tested in trial NCT00212264?

The interventions under investigation include: Biofeedback (BEHAVIORAL), No Treatment (OTHER), Behavioral Therapy (BEHAVIORAL), Pelvic Floor Electrical Stimulation (DEVICE).

Who is sponsoring clinical trial NCT00212264?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00212264's enrollment target sits among peer trials

208 496th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465774 · 208 participants

    Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions

  • NCT03803332 · 208 participants · NA

    A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel

  • NCT04732065 · 208 participants · Phase 1

    ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

  • NCT05293756 · 208 participants · NA

    OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00212264, the US trial registry maintained by the National Library of Medicine. NCT00212264 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.